President Joe Biden ordered aides to find answers to the origin of the virus that causes Covid-19, saying on May 26 that U.S. intelligence agencies are pursuing rival theories potentially including the possibility of a laboratory accident in China.
AbbVie exploits the U.S. patent system to push up prices for the company’s Humira rheumatoid arthritis drug and cancer medicine Imbruvica, according to a U.S. House of Representatives Oversight Committee staff report on May 18.
U.S. lawmakers from both parties and both houses of Congress introduced eight antitrust bills aimed at tackling the problem of high and rising drug prices, including bills to stop brand name drug companies from paying generic firms to stay off the market.
President Joe Biden scored his first legislative win as the House of Representatives passed his $1.9 trillion coronavirus relief package early Feb. 27, though Democrats face challenges to their hopes of using the bill to raise the minimum wage.
Johnson & Johnson expects to be able to ship nearly 4 million doses of the company’s Covid-19 vaccine upon authorization in the U.S., an executive said at a hearing in the U.S. House of Representatives on Feb. 23.
The U.S. Congress approved an $892 billion coronavirus aid package, throwing a lifeline to the nation’s pandemic-battered economy after months of inaction, while also keeping the federal government funded.
Warren Buffett, one of America’s best-known investors, is backing multiple pharmaceutical companies developing therapies aimed at curbing the ongoing global Covid-19 pandemic.
The U.S. House of Representatives approved a $3.2 billion budget proposal for the U.S. Food and Drug Administration that will boost the regulatory agency’s abilities to approve new medicines and medical devices, as well as protect the nation’s food supplies.
In an ongoing online hearing before the House Committee on Energy and Commerce’s Oversight and Investigation subcommittee, executives from across the pharmaceutical industry outlined the steps their companies are taking to combat Covid-19 and restore the world to a sense of normalcy.
President Donald Trump will sign three executive orders on lowering prescription drug prices, White House Chief of Staff Mark Meadows said.